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Human papillomaviruses (HPV) remain a serious world
health problem due to their association with anogenital
and oral cancers and warts. While over 100 HPV types
have been identified, only a subset is associated with
malignancy. HPV16 and 18 are the most common onco-
genic types, while HPV6 and 11 are the most common
types responsible for anogenital warts. These four types
cause up to 90% of HPV-associated disease. While other
quantitative PCR (qPCR) assays can be used to detect
oncogenic HPV, there is no single tube assay that distin-
guishes the most frequent oncogenic types and the most
common types found in warts. A qPCR assay was devel-
oped that allowed for detection and quantitation of
these 4 HPV types. Type-specific primer pairs and Taq-
Man probes allowed single tube multiplex reactions to
be performed. Each HPV type was detected over a range
from 2 Η 101 to 2 Η 106 copies/reaction, providing a
reliable method of quantitating type-specific HPV.
A Sybr Green-based qPCR assay was developed that uti-
lizes degenerate primers targeting the E1 region of all
HPVs. These assays were run in parallel with PCR/
sequence gold standard on 76 oral cancers from HIV-
negative individuals. Cervical and oral washes were
collected from 25 HIV-positive women and 90 HIV-
positive men, respectively, being screened for anogenital
neoplasia. Samples were analyzed using the newly devel-
oped assays. Of the 115 samples, 16% were HPV posi-
tive. Cervical washes contained HPV types 44, 67, 35,
and 68 and oral specimens contained HPV types 16, 11,
32, 6, 55, 73, and 70. These results indicate that these
assays can be used to detect and quantitate HPV in clin-
ical samples obtained by noninvasive measures.
Acknowledgements
This work was supported in part by NIDCR OHARA 1 U01 AI068636-01.
This article has been published as part of Infectious Agents and Cancer
Volume 5 Supplement 1, 2010: Proceedings of the 12th International
Conference on Malignancies in AIDS and Other Acquired
Immunodeficiencies (ICMAOI). The full contents of the supplement are
available online at http://www.biomedcentral.com/1750-9378/5?issue=S1.
Author details
1Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
2Division of Infectious Disease, University of North Carolina, Chapel Hill, NC,
USA. 3Department of Microbiology and Immunology, University of North
Carolina School of Medicine, Chapel Hill, NC, USA. 4Department of Dental
Ecology, University of North Carolina School of Dentistry, Chapel Hill, NC,
USA. 5Division of Biology and Medicine, Brown University, Providence,
RI, USA.
Published: 11 October 2010
doi:10.1186/1750-9378-5-S1-A17
Cite this article as: Seaman et al.: Detection and quantitation of HPV in
anogenital and oral tissues and fluids of HIV-positive individuals by
real-time PCR. Infectious Agents and Cancer 2010 5(Suppl 1):A17.
*Correspondence: tseaman@med.unc.edu
1Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA
Full list of author information is available at the end of the article
Seaman et al. Infectious Agents and Cancer 2010, 5(Suppl 1):A17
http://www.infectagentscancer.com/content/5/S1/A17
© 2010 Seaman et al; licensee BioMed Central Ltd.
